Want to see GB:COIL full AI Analyst Report?

Roquefort Investments PLC (COIL) Price & Analysis

2 Followers

COIL Stock Chart & Stats

1.20 p

-0.08 p(-2.08%)

At close: Jan 09 4:00 PM EST

1.20 p

-0.08 p(-2.08%)

Day’s Range― - ―

52-Week Range6.75 p - 30.00 p

Previous CloseN/A

VolumeN/A

Average Volume (3M)2.61M

Market Cap

£36.28M

Enterprise Value356.27K

Total Cash (Recent Filing)£182.92K

Total Debt (Recent Filing)£383.65K

Price to Earnings (P/E)―

Beta0.48

Next Earnings

Sep 24, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.06

Shares Outstanding426,791,320

10 Day Avg. Volume1,674,162

30 Day Avg. Volume2,613,232

Financial Highlights & Ratios

PEG Ratio0.12

Price to Book (P/B)1.07

Price to Sales (P/S)0.00

P/FCF Ratio-6.70

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Roquefort Investments PLC News

Coiled Therapeutics Shifts London Headquarters as Lead Cancer Drug Advances in Trials

Roquefort Investments PLC ( ($GB:COIL) ) has provided an update. Coiled Therapeutics plc, a clinical-stage precision oncology company...

18d ago

Coiled Therapeutics launches optimised AO-252 softgel in U.S. Phase I study

An announcement from Roquefort Investments PLC ( ($GB:COIL) ) is now available. Coiled Therapeutics has dosed the first...

25d ago

Coiled Therapeutics Advances Next-Generation AO-252 Softgel Ahead of Dose Expansion

Roquefort Investments PLC ( ($GB:COIL) ) has issued an announcement. Coiled Therapeutics has developed a next-generation lipid-based softgel...

2M ago

Coiled Therapeutics Publishes Investor Presentation as Lead Cancer Drug Advances in Phase I

Roquefort Investments PLC ( ($GB:COIL) ) has shared an update. Coiled Therapeutics plc, a clinical-stage oncology company listed...

2M ago

Coiled Therapeutics AGM Backs Strategy but Votes Down Director Reappointment

Roquefort Investments PLC ( ($GB:COIL) ) has issued an update. Coiled Therapeutics plc reported the results of its...

2M ago

Coiled Therapeutics Adds Veteran Biotech Dealmaker Craig Tooman to Board

The latest announcement is out from Roquefort Investments PLC ( ($GB:COIL) ). Coiled Therapeutics has appointed seasoned biotech...

2M ago

Coiled Therapeutics to Present Precision Oncology Pipeline at Investor Forum

Roquefort Investments PLC ( ($GB:COIL) ) has shared an update. Coiled Therapeutics plc will showcase its pipeline to...

2M ago

Coiled Therapeutics to showcase oncology pipeline at London investor forum

Roquefort Investments PLC ( ($GB:COIL) ) has provided an update. Coiled Therapeutics will present to investors at the...

2M ago

Coiled Therapeutics Grants 6.2 Million Share Options to Strengthen Leadership Incentives

Roquefort Investments PLC ( ($GB:COIL) ) just unveiled an announcement. Coiled Therapeutics has granted 6.2 million share options...

2M ago

Coiled Therapeutics Strengthens Clinical Leadership for AO-252 With New Advisory Board

Roquefort Investments PLC ( ($GB:COIL) ) has issued an update. Coiled Therapeutics has formed a Medical Advisory Board...

2M ago

COIL FAQ

What was Roquefort Investments PLC’s price range in the past 12 months?

Roquefort Investments PLC lowest share price was 6.75 p and its highest was 30.00 p in the past 12 months.

What is Roquefort Investments PLC’s market cap?

Roquefort Investments PLC’s market cap is £36.28M.

When is Roquefort Investments PLC’s upcoming earnings report date?

Roquefort Investments PLC’s upcoming earnings report date is Sep 24, 2026 which is in 27 days.

How were Roquefort Investments PLC’s earnings last quarter?

Roquefort Investments PLC released its earnings results on May 06, 2026. The company reported -0.175 p earnings per share for the quarter, missing the consensus estimate of N/A by -0.175 p.

Is Roquefort Investments PLC overvalued?

According to Wall Street analysts Roquefort Investments PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Roquefort Investments PLC pay dividends?

Roquefort Investments PLC does not currently pay dividends.

What is Roquefort Investments PLC’s EPS estimate?

Roquefort Investments PLC’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Roquefort Investments PLC have?

Roquefort Investments PLC has 426,791,320 shares outstanding.

What happened to Roquefort Investments PLC’s price movement after its last earnings report?

Roquefort Investments PLC reported an EPS of -0.175 p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Roquefort Investments PLC?

Currently, no hedge funds are holding shares in GB:COIL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Roquefort Investments PLC Stock Smart Score

Underperform

Insider Transactions

Bought Shares

Worth £85.0K over
the Last 3 Months

Technicals

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

-53.17%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Roquefort Investments PLC

Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.